ASRM 2019 — Aneuploidy: preimplantation genetic testing improves perinatal outcomes


  • Daniel M. Keller, Ph.D
  • Conference Reports
L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano L'accesso ai contenuti di questo sito è riservato agli operatori del settore sanitario italiano

Takeaway

  • Preimplantation genetic testing and frozen embryo transfer (PGT-FET) has several benefits on perinatal outcomes of the newborn, including lower risk of low birth weight (LBW) and preterm delivery.
  • No harms resulted from biopsy of the embryo.

Why this matters

  • Studies have shown differences in LBW and preterm delivery following in vitro fertilization vs natural conception.
  • PGT and FET are increasingly common, but perinatal outcomes have not been studied.

Study design  

  • Retrospective cohort study using Society for Assisted Reproductive Technology database.
  • Compared day-5 autologous FET cycles undergoing PGT (n=10,367) vs no PGT (n=39,570).
  • Financial support: None.

Key results

  • PGT group mean age: 35.6 vs 33.9 years no PGT (P<.01>
  • Mean number of embryos transferred: PGT 1.2 vs no PGT 1.6 (P<.01>
  • Primary outcome — LBW rate: PGT 16.5% vs no PGT 23.8% (adjusted risk ratio [aRR], 0.74; 95% CI, 0.66-0.83).
  • Clinical pregnancy rate: PGT 64.9% vs no PGT 57.7% (aRR, 1.16; 95% CI, 1.13-1.19).
  • Live birth rate: PGT 56.2% vs no PGT 46.8% (aRR, 1.25; 95% CI, 1.21-1.30).
  • Multiple gestation rate: PGT 12.6% vs no PGT 21.4% (aRR, 0.68; 95% CI, 0.60-0.77).

Limitations

  • Could not determine day of biopsy from data set.
  • Information could be missing from data set.